DISEASE SCANNER
Global Incurable Diseases Tracker
Neurofibromatosis Type 1
An autosomal dominant disorder caused by NF1 gene mutations, characterized by multiple neurofibromas, café-au-lait spots, and learning disabilities. Increased risk of malignancies including malignant peripheral nerve sheath tumors.
2.5M
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Genetic testing
- 2Clinical evaluation
- 3Family history assessment
- 4Specialized laboratory tests
- 5Imaging studies
- 6Biopsy (if applicable)
Prognosis
Variable. Most have normal lifespan. Malignant transformation in 3-5%. Learning disabilities common but manageable. Pain can be significant. MEK inhibitors transforming care for severe cases.
Prevention
- Genetic counseling
- Carrier screening
- Prenatal diagnosis
- Preimplantation genetic diagnosis
- Family planning
Research Status
MEK inhibitors (selumetinib) for inoperable plexiform neurofibromas. Surgery for symptomatic tumors. Regular cancer surveillance. Multidisciplinary care for complications.
Affected Countries
Sources
- https://www.ncbi.nlm.nih.gov/books/NBK1116
- https://medlineplus.gov/genetics
- https://rarediseases.org
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.